This opportunity uses the R01 Research Project Grant funding mechanism.
The National Cancer Institute (NCI) seeks research project (R01) grant applications describing projects that integrate imaging and fluid-based tumor monitoring (liquid biopsy) assays during cancer therapy in patients to determine the optimal use of those modalities in the characterization of therapy response and/or emergence of resistance.
Funding & Duration
Application budgets are limited to US $499,999 (approx. AUD $730,000) in direct costs per year. The maximum project period is 5 years.
Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Submission Requirements & Due Date
- Applications must be submitted for internal review by 27 September 2019
- Please email firstname.lastname@example.org if you are considering applying for this scheme.
- See also: Submitting an Application to Research Services for Review